The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls

European Neuropsychopharmacology

Volumn 19, Issue 1, 2009, Pages 68-73

  Schellekens, Arnt F A ^a,b   van Oosterwijck, Armand W A A ^a   Ellenbroek, Bart ^c   de Jong, Cor A J ^b   Buitelaar, Jan K ^a   Cools, Lex ^a   Verkes, Robbert Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c EVOTEC AG   (Germany)

Author keywords

Alcohol dependence; Apomorphine; Cognition; Dopamine

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; HUMAN; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REACTION TIME; TASK PERFORMANCE;

ADULT; ALCOHOLISM; APOMORPHINE; COGNITION; DIAGNOSIS, DUAL (PSYCHIATRY); DOPAMINE; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, DOPAMINE; SOCIOECONOMIC FACTORS;

EID: 57049102873     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.08.006     Document Type: Article

References (28)

1. Backman L., Ginovart N., Dixon R.A., Wahlin T.B., Wahlin A., Halldin C., and Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry 157 4 (2000) 635-637
2. Braver T.S., and Barch D.M. A theory of cognitive control, aging cognition, and neuromodulation. Neurosci. Biobehav. Rev. 26 7 (2002) 809-817
3. Braver T.S., Barch D.M., Keys B.A., Carter C.S., Cohen J.D., Kaye J.A., Janowsky J.S., Taylor S.F., Yesavage J.A., Mumenthaler M.S., Jagust W.J., and Reed B.R. Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. J. Exp. Psychol. Gen. 130 4 (2001) 746-763
4. Chanraud S., Martelli C., Delain F., Kostogianni N., Douaud G., Aubin H.J., Reynaud M., and Martinot J.L. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 32 2 (2007) 429-438
5. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex 11 12 (2001) 1136-1143
6. Cropley V.L., Fujita M., Innis R.B., and Nathan P.J. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol. Psychiatry 59 10 (2006) 898-907
7. Ellenbroek B.A., van der Kam E.L., van der Elst M.C., and Cools A.R. Individual differences in drug dependence in rats: the role of genetic factors and life events. Eur. J. Pharmacol. 526 1-3 (2005) 251-258
8. Fletcher P.C., Frith C.D., Grasby P.M., Friston K.J., and Dolan R.J. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J. Neurosci. 16 21 (1996) 7055-7062
9. Friston K.J., Grasby P.M., Bench C.J., Frith C.D., Cowen P.J., Liddle P.F., Frackowiak R.S., and Dolan R. Measuring the neuromodulatory effects of drugs in man with positron emission tomography. Neurosci. Lett. 141 1 (1992) 106-110
10. Grasby P.M., Friston K.J., Bench C.J., Cowen P.J., Frith C.D., Liddle P.F., Frackowiak R.S., and Dolan R.J. The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers. Psychol. Med. 23 3 (1993) 605-612
11. Harper C., and Matsumoto I. Ethanol and brain damage. Curr. Opin. Pharmacol. 5 1 (2005) 73-78
12. Heinz A., Lichtenberg-Kraag B., Baum S.S., Graf K., Kruger F., Dettling M., and Rommelspacher H. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J. Neural Transm. Gen. Sect. 102 2 (1995) 149-157
13. Iversen S.D., and Iversen L.L. Dopamine: 50 years in perspective. Trends Neurosci. 30 5 (2007) 188-193
14. Langeland W., van den B.W., Draijer N., and Hartgers C. Sensitivity of the Addiction Severity Index physical and sexual assault items: preliminary findings on gender differences. Eur. Addict. Res. 7 4 (2001) 193-197
15. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H.L., and O'Brien C.P. New data from the Addiction Severity Index. Reliability and validity in three centers. J. Nerv. Ment. Dis. 173 7 (1985) 412-423
16. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9 3 (1992) 199-213
17. Nader M.A., and Czoty P.W. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am. J. Psychiatry 162 8 (2005) 1473-1482
18. Reeves S.J., Grasby P.M., Howard R.J., Bantick R.A., Asselin M.C., and Mehta M.A. A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 28 1 (2005) 216-226
19. Sandra Kooij J.J., Marije B.A., Swinkels S.H., Bekker E.M., de, N. I., and Buitelaar J.K. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J. Atten. Disord. 11 4 (2008) 445-458
20. Savitz J., Solms M., and Ramesar R. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav. 5 4 (2006) 311-328
21. Schmidt L.G., Dettling M., Graef K.J., Heinz A., Kuhn S., Podschus J., and Rommelspacher H. Reduced dopaminergic function in alcoholics is related to severe dependence. Biol. Psychiatry 39 3 (1996) 193-198
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 Suppl 20 (1998) 22-33
23. van Vliet I., and de Beurs E. [The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders]. Tijdschr. Psychiatr. 49 6 (2007) 393-397
24. van der Linden D., Massar S.A., Schellekens A.F., Ellenbroek B.A., and Verkes R.J. Disrupted sensorimotor gating due to mental fatigue: preliminary evidence. Int. J. Psychophysiol. 62 1 (2006) 168-174
25. van der Kam E.L., Ellenbroek B.A., and Cools A.R. Gene - environment interactions determine the individual variability in cocaine self-administration. Neuropharmacology 48 5 (2005) 685-695
26. Vijayraghavan S., Wang M., Birnbaum S.G., Williams G.V., and Arnsten A.F. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 10 3 (2007) 376-384
27. Volkow N.D., Fowler J.S., Wang G.J., and Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9 6 (2004) 557-569
28. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M., and Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 64 11 (2007) 1575-1579